NYSE:AME - New York Stock Exchange, Inc. - US0311001004 - Common Stock - Currency: USD
AMETEK, Itron and Cognex gain from 5G and automation tailwinds despite macro headwinds weighing on the electronics testing industry.
The biotech pioneer posted strong Q1 2025 results with 14 drugs delivering double-digit sales growth. Amgen (NASDAQ: AMGN) is doing something unusual in 2025. Here's why this $150 billion pharmaceutical powerhouse deserves a closer look by investors of all stripes.
NEW YORK (Reuters) -U.S. stocks ended higher on Thursday as shares of Nvidia gained after its quarterly results, while investors digested a late-afternoon court ruling that reinstated the most sweeping of President Donald Trump's tariffs. The appeals court ruling came a day after a trade court had ordered an immediate block on the tariffs. Trading was choppy for much of the day and indexes ended well off their highs of the session, however, with investors trying to digest the rulings and as shares of Salesforce fell 3.3%.
On May 27, Coupang Inc. (NYSE:CPNG) was named a Top Pick by Morgan Stanley analyst Seyon Park, who also maintained his Overweight rating and raised the price target from $27 to $32. Park highlighted several drivers for his rating, the foremost being the company’s strong execution and low impact from tariffs. The company also benefits […]
/PRNewswire/ -- The Board of Directors of AMETEK, Inc. (NYSE: AME) declared a regular quarterly dividend of $0.31 per share for the second quarter ending June...
/PRNewswire/ -- AMETEK, Inc. (NYSE: AME) and FARO Technologies, Inc. (Nasdaq: FARO) today announced that they have entered into a definitive agreement under...
Mentions: FARO
The Zacks Electronics -Testing Equipment industry players, such as AME, ITRI and CGNX, are poised to benefit from the solid demand for testing instruments.
The Benzinga Stock Whisper Index highlights five stocks seeing increased interest from readers during the week and a look at what's drivin the interest.
/PRNewswire/ -- AMETEK, Inc. (NYSE: AME) today announced its financial results for the first quarter ended March 31, 2025. AMETEK's first quarter 2025 sales...
Back in 2024, on May 14, a caller asked about AMETEK, Inc (NYSE:AME), praising its chart and its role in electromechanical devices and gas analyzers for the semiconductor industry at the time. Cramer was enthusiastic back then, saying: “Oh man, come on, AME? Just one of the great industrials too. I mean, absolutely terrific company. […]
Today's Research Daily features new research reports on 16 major stocks, including Advanced Micro Devices, Inc. (AMD), Union Pacific Corporation (UNP) and Lowe's Companies, Inc. (LOW), as well a micro-cap stock Syntec Optics Holdings, Inc. (OPTX).
Review Ametek's (AME) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
/PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market...
Under the agreement, AMETEK is offering $44 per share in cash, representing about a 40% premium to FARO's last close. FARO Technologies, which produces 3D measurement and imaging solutions including portable measurement arms, laser scanners and trackers, among others, generated about $340 million in sales in 2024. The transaction will boost AMETEK's precision technology portfolio in the electronic instruments division, which produces test and measurement instruments for sectors such as aerospace, medical, research, power and industrial markets.
Mentions: FARO
FTV's Q1 earnings match estimates and rise year over year, but revenues decline and miss forecasts. Management lowers full-year EPS guidance.
/PRNewswire/ -- AMETEK, Inc. (NYSE: AME) will issue its first quarter 2025 earnings release before the market opens on Thursday, May 1, 2025. AMETEK will...
AME's first-quarter 2025 results reflect the company's declining sales growth in the Electronic Instruments Group segment.
The headline numbers for Ametek (AME) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Cognex (CGNX) delivered earnings and revenue surprises of 23.08% and 5.72%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: CGNX
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Ametek (AME), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2025.
Ametek (AME) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mentions: CGNX
Ametek (AME) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.